SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-041120
Filing Date
2024-03-29
Accepted
2024-03-29 15:33:30
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 tm2213007-9_424b5.htm 424B5 1062143
2 GRAPHIC lg_adagene-4clr.jpg GRAPHIC 12592
3 GRAPHIC tm2213007d1-pc_neobody4c.jpg GRAPHIC 320003
4 GRAPHIC tm2213007d1-tbl_program4c.jpg GRAPHIC 105986
5 GRAPHIC tm2213007d1-fc_corpobw.jpg GRAPHIC 89307
  Complete submission text file 0001104659-24-041120.txt   1789935
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Filer) CIK: 0001818838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264486 | Film No.: 24803955
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)